USC/Norris Comprehensive Cancer Center, Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Local Institution - 0428, San Francisco

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07221149

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

City of Hope, Duarte

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
и још 22

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
и још 10

Тражи се учесникЗдраве особе су добродошле

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07283939

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
и још 10

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Cedars-Sinai Medical Center, Los Angeles

Тражи се учесникФаза 4

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07124351

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

UCSD, La Jolla
Sharp Healthcare, San Diego

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03526835

Lead-212 PSV359 Therapy for Patients With Solid Tumors

VA Greater Los Angeles Healthcare System, Los Angeles
UCLA Department of Medicine - Hematology/Oncology, Los Angeles

Тражи се учесникФаза 1/2

Узраст од 18 до 90 · Оба пола · Ажурирано 28. 10. 2026. · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

City of Hope Duarte, Duarte
University of California at Los Angeles, Santa Monica

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07529808

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Helios CR Inc./RadNet, Cerritos
City of Hope National Cancer Center, Duarte
Hoag Memorial Hospital, Irvine
и још 2

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07217704

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Duarte
Research Site, Fountain Valley
Research Site, Fullerton
и још 6

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07431281

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06293898

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Burbank, Burbank
UCLA Hematology/Oncology - Encino, Encino
и још 7

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07392892

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco, San Francisco

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07070232

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

City of Hope, Duarte
City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
University of California, Los Angeles, Santa Monica

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06038578

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site, Orange
Research Site, Palo Alto
Research Site, Santa Rosa

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT06219941

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

UCLA Health, Los Angeles

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07700979

IKS014 in Advanced Solid Tumors That Express HER2

Hoag Memorial Hospital Presbyterian, Newport Beach

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT05872295

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

Тражи се учесникФаза 2

Узраст од 18 до 130 · Оба пола · Ажурирано 23. 9. 2026. · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Stanford Cancer Center, Palo Alto

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05274048

A Phase 1/1b Study of IAM1363 in HER2 Cancers

UCSD Moores Cancer Center, La Jolla
USC Norris Comprehensive Cancer Center, Los Angeles

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07795749

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

UCLA, Santa Monica

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 28. 8. 2026. · NCT07070466

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

UC San Diego Moores Cancer Center, San Diego

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 27. 8. 2026. · NCT07227168

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center, Duarte

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT04329494

Patient-Derived Xenografts to Reduce Cancer Health Disparities

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
University of California Davis Comprehensive Cancer Center, Sacramento

Тражи се учесникОпсервациона студија

Узраст од 21 до 100 · Оба пола · Ажурирано 20. 8. 2026. · NCT04410302

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco, San Francisco
John Muir Medical Center-Walnut Creek, Walnut Creek

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT04221893

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

ULCA, Los Angeles
UCSF, San Francisco

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT07066657

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #101, San Diego

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT06974110

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.